Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy

Multiple sclerosis (MS) is a leading cause of chronic neurological disability in young to middle-aged adults, affecting ~2.5 million people worldwide. Currently, most therapeutics for MS are systemic immunosuppressive or immunomodulatory drugs, but these drugs are unable to halt or reverse the disea...

Full description

Saved in:
Bibliographic Details
Published in:Cell Mol Immunol
Main Authors: Mansilla, M. J., Presas-Rodríguez, S., Teniente-Serra, A., González-Larreategui, I., Quirant-Sánchez, B., Fondelli, F., Djedovic, N., Iwaszkiewicz-Grześ, D., Chwojnicki, K., Miljković, Đ., Trzonkowski, P., Ramo-Tello, C., Martínez-Cáceres, E. M.
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2021
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8167140/
https://ncbi.nlm.nih.gov/pubmed/33958746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41423-020-00618-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items